Pfizer Raises 2026 Outlook After Q3 Results Beat Estimates
Photo: TokenPost
Pfizer lifted its 2026 outlook after third-quarter earnings and revenue exceeded analyst projections. The company also appointed Cecile Guegan chief financial officer. Non-GAAP earnings reached 87 cents per share, 14 cents above estimates. Revenue totaled $16.58 billion, topping forecasts by $700 million. Before the release, analysts had projected earnings of 73 cents per share and revenue of $15.88 billion in the pre-report estimates . John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
